Tata Chemicals Limited has informed the Exchange regarding a press release dated May 04, 2026, titled "Audited Consolidated and Standalone Financial Results of the Company for the quarter and financial year ended March 31, 2026".
TATACHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Tata Chemicals reported consolidated revenue of ₹ 3,438 Cr for Q4FY26, down 2% YoY, with EBITDA at ₹ 274 Cr (vs ₹ 327 Cr in Q4FY25). The company took an exceptional charge of ₹ 1,837 Cr for goodwill impairment in US operations and ₹ 159 Cr deferred tax assets write-off. Q4 PAT (before exceptional items) turned significantly negative at ₹ (279) Cr compared to ₹ (12) Cr in Q4FY25. For full year FY26, consolidated revenue was ₹ 14,584 Cr (down 2%) and EBITDA at ₹ 1,805 Cr (vs ₹ 1,953 Cr), with PAT declining to ₹ 241 Cr from ₹ 479 Cr. Standalone performance was relatively better with 9% revenue growth to ₹ 4,831 Cr and 18% PAT growth to ₹ 620 Cr. The company completed acquisition of Novabay Pte. Limited in March 2026.
The substantial goodwill impairment and negative PAT indicate severe stress on US soda ash operations due to unsustainable export prices. Despite resilient standalone performance, consolidated results show the company is navigating a challenging global soda ash market with pricing pressure across geographies.